SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-045240
Filing Date
2018-08-17
Accepted
2018-08-17 06:59:35
Documents
5
Period of Report
2018-09-21
Effectiveness Date
2018-08-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv500398-def14a.htm DEF 14A 812881
2 GRAPHIC lg_oncobiologics.jpg GRAPHIC 118526
3 GRAPHIC tv500398_pc1.jpg GRAPHIC 345464
4 GRAPHIC tv500398_pc2.jpg GRAPHIC 246536
5 GRAPHIC tv500398_pc3.jpg GRAPHIC 435472
  Complete submission text file 0001144204-18-045240.txt   2379076
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Oncobiologics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37759 | Film No.: 181024719
SIC: 2836 Biological Products, (No Diagnostic Substances)